Literature DB >> 19765232

The prevalence of impaired fasting glucose and type 2 diabetes in a population-based sample of overweight/obese children in the Middle East.

Mohammad Hasan Moadab1, Roya Kelishadi, Mahin Hashemipour, Masoud Amini, Parinaz Poursafa.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (T2DM) and impaired fasting glucose (IFG) are increasing in young population who are facing an escalating trend of overweight. The aim of this study was to determine the prevalence of IFG and T2DM for the first time in a population-based sample of Iranian obese children.
METHODS: This cross-sectional, population-based study was conducted in Isfahan, the second large city of Iran. Overall, 672 overweight and obese school students, selected from 7554 students, aged 6-19 yr, were screened for IFG and T2DM. Fasting plasma glucose (FPG) and lipid profile were measured in all participants. Oral glucose tolerance test and insulin level were measured in those children with IFG. Insulin resistance was defined as homeostasis model assessment for insulin resistance (HOMA-IR) > 3.10.
RESULTS: Among the7554 students (48.7% boys and 51.3% girls) studied, 9.34% (n = 706) were overweight and 5.3% (n = 403) were obese. A number of 672 overweight and obese students including 302 (44.9%) boys and 370 (55.1%) girls, with a mean age of 12.8 +/- 3.10 yr underwent biochemical work up. Overall, the prevalence of IFG was 4.61% (n = 31), the corresponding figure was 2% (n = 4) in the 6-10 yr age group, and 5% (n = 27) in those aged 10.1-19 yr. The prevalence of T2DM was 0.1% (n = 1; age, 18.00 yr). Impaired glucose tolerance and insulin resistance were detected in three and six participants with IFG, who consisted 0.4 and 0.8% of total obese and overweight students, respectively.
CONCLUSIONS: Although the prevalence of T2DM is low in Iranian obese children, IFG is not uncommon. Preventive measures and screening of FPG should be considered for these children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765232     DOI: 10.1111/j.1399-5448.2009.00534.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  6 in total

1.  Prevalence and risk factors of diabetes and impaired fasting glucose among university applicants in Eastern China: findings from a population-based study.

Authors:  C Hao; C Zhang; W Chen; Z Shi
Journal:  Diabet Med       Date:  2014-05-20       Impact factor: 4.359

2.  Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese Spanish children and adolescents.

Authors:  M P Bahíllo-Curieses; F Hermoso-López; M J Martínez-Sopena; P Cobreros-García; P García-Saseta; M Tríguez-García; J M Marugán-Miguelsanz
Journal:  Endocrine       Date:  2011-10-01       Impact factor: 3.633

3.  Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents.

Authors:  Roya Kelishadi; Stephen R Cook; Atoosa Adibi; Zahra Faghihimani; Shohreh Ghatrehsamani; Abolfazl Beihaghi; Hamidreza Salehi; Noushin Khavarian; Parinaz Poursafa
Journal:  Diabetol Metab Syndr       Date:  2009-12-22       Impact factor: 3.320

4.  Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China.

Authors:  Chundan Bao; Dianfeng Zhang; Bo Sun; Li Lan; Wenxiu Cui; Guohua Xu; Conglan Sui; Yibaina Wang; Yashuang Zhao; Jian Wang; Hongyuan Li
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 5.  Coronary artery disease and its risk factors status in iran: a review.

Authors:  M Ebrahimi; S M R Kazemi-Bajestani; M Ghayour-Mobarhan; G A A Ferns
Journal:  Iran Red Crescent Med J       Date:  2011-09-15       Impact factor: 0.611

6.  Parental perceptions of weight status of their children.

Authors:  Nizal Sarrafzadegan; Katayoun Rabiei; Fatemeh Nouri; Noushin Mohammadifard; Fariborz Moattar; Hamidreza Roohafza; Shaghayegh Haghjooy Javanmard; Sonia Zarfeshani; Masoud Pourmoghaddas
Journal:  ARYA Atheroscler       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.